HealthServier Reports 37.2-Month PFS in Vorasidenib Glioma Crossover AnalysisBy Naomi CalderNov 18, 2026, 11:52 AM UTC
HealthIDEAYA Shares Darovasertib Findings From Three Uveal Melanoma StudiesBy Naomi CalderOct 19, 2026, 4:44 PM UTC